The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis.
Saved in:
| Title: | The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis. |
|---|---|
| Authors: | Wells M; Department of Clinical Specialties and Related Sciences, University of Bristol, Bristol, UK.; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK.; Department of Rheumatology, North Bristol NHS Trust, Bristol, UK., Smith T; Department of Mathematical Sciences, University of Bath, Bath, UK., Domsic RT; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA., Anilkumar A; Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK., Frech TM; Vanderbilt University, Nashville, TN, USA., Herrick AL; Centre for Musculoskeletal Research, University of Manchester, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.; National Institute for Health and Care Research (NIHR), Manchester Biomedical Research Centre, Manchester, UK., Hummers LK; Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Shah AA; Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Denton CP; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital, London, UK., Khanna D; University of Michigan Scleroderma Program, Ann Arbor, MI, USA.; Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA., Barratt SL; Department of Clinical Specialties and Related Sciences, University of Bristol, Bristol, UK.; Academic Respiratory Unit, Department of Clinical Sciences, University of Bristol, Bristol, UK., Pauling JD; Department of Clinical Specialties and Related Sciences, University of Bristol, Bristol, UK.; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK.; Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, Bristol, UK. |
| Source: | Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2026 Jun 03; Vol. 65 (6). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN: 1462-0332 (Electronic) Linking ISSN: 14620324 NLM ISO Abbreviation: Rheumatology (Oxford) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42172612 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wells+M%22">Wells M</searchLink>; Department of Clinical Specialties and Related Sciences, University of Bristol, Bristol, UK.; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK.; Department of Rheumatology, North Bristol NHS Trust, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Smith+T%22">Smith T</searchLink>; Department of Mathematical Sciences, University of Bath, Bath, UK.<br /><searchLink fieldCode="AU" term="%22Domsic+RT%22">Domsic RT</searchLink>; Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Anilkumar+A%22">Anilkumar A</searchLink>; Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK.<br /><searchLink fieldCode="AU" term="%22Frech+TM%22">Frech TM</searchLink>; Vanderbilt University, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Herrick+AL%22">Herrick AL</searchLink>; Centre for Musculoskeletal Research, University of Manchester, Northern Care Alliance NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.; National Institute for Health and Care Research (NIHR), Manchester Biomedical Research Centre, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Hummers+LK%22">Hummers LK</searchLink>; Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Shah+AA%22">Shah AA</searchLink>; Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Denton+CP%22">Denton CP</searchLink>; Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Khanna+D%22">Khanna D</searchLink>; University of Michigan Scleroderma Program, Ann Arbor, MI, USA.; Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Barratt+SL%22">Barratt SL</searchLink>; Department of Clinical Specialties and Related Sciences, University of Bristol, Bristol, UK.; Academic Respiratory Unit, Department of Clinical Sciences, University of Bristol, Bristol, UK.<br /><searchLink fieldCode="AU" term="%22Pauling+JD%22">Pauling JD</searchLink>; Department of Clinical Specialties and Related Sciences, University of Bristol, Bristol, UK.; Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol, UK.; Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, Bristol, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100883501%22">Rheumatology (Oxford, England)</searchLink> [Rheumatology (Oxford)] 2026 Jun 03; Vol. 65 (6). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883501 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1462-0332 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214620324%22">14620324 </searchLink><i>NLM ISO Abbreviation: </i>Rheumatology (Oxford) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42172612 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/rheumatology/keag267 Languages: – Code: eng Text: English Titles: – TitleFull: The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wells M – PersonEntity: Name: NameFull: Smith T – PersonEntity: Name: NameFull: Domsic RT – PersonEntity: Name: NameFull: Anilkumar A – PersonEntity: Name: NameFull: Frech TM – PersonEntity: Name: NameFull: Herrick AL – PersonEntity: Name: NameFull: Hummers LK – PersonEntity: Name: NameFull: Shah AA – PersonEntity: Name: NameFull: Denton CP – PersonEntity: Name: NameFull: Khanna D – PersonEntity: Name: NameFull: Barratt SL – PersonEntity: Name: NameFull: Pauling JD IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 06 Text: 2026 Jun 03 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1462-0332 Numbering: – Type: volume Value: 65 – Type: issue Value: 6 Titles: – TitleFull: Rheumatology (Oxford, England) Type: main |
| ResultId | 1 |